Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Oxcarbazepine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbazepine antiepileptic (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely carbamazepine 200 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbazepine antiepileptic (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbamazepine 200mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbazepine antiepileptic (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbamazepine 400mg m/r tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbazepine antiepileptic (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely carbamazepine 125 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbazepine antiepileptic (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbamazepine 250 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbazepine antiepileptic (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbamazepine 200 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbazepine antiepileptic (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbamazepine 100 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbazepine antiepileptic (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely oxcarbazepine 150 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbazepine antiepileptic (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely oxcarbazepine 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbazepine antiepileptic (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxcarbazepine 600 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbazepine antiepileptic (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbazepine antiepileptic (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbazepine antiepileptic (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbamazepine 100mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbazepine antiepileptic (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbamazepine 300mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbazepine antiepileptic (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbamazepine 200mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbazepine antiepileptic (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbamazepine 100mg/5 mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbazepine antiepileptic (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing carbamazepine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbazepine antiepileptic (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbamazepine-containing product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbazepine antiepileptic (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxcarbazepine 300mg/5 mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbazepine antiepileptic (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbamazepine 100mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbazepine antiepileptic (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oral form carbamazepine m/r |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbazepine antiepileptic (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing carbamazepine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbazepine antiepileptic (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbamazepine 100mg/5mL oral liquid (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbazepine antiepileptic (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxcarbazepine 60mg/mL s/f oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbazepine antiepileptic (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbamazepine 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbazepine antiepileptic (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely carbamazepine 400 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbazepine antiepileptic (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|